MS3 synchronous precursor selection workflow Mass spectra were collected on a Fusion Lumos mass spectrometer (Thermo Fisher Scientific) in a data-dependent MS3 synchronous precursor selection (SPS) method 17
Plasma Concentration-Time Profiles The plasma concentrationtime profiles of panduratin A after intravenous administration of panduratin A and oral administration of panduratin A and fingerroot extract are shown in Figure 2
2 Nonstandard administration of dose-reduced DOACs beyond the well-defined indications for dose-adjusted or low-intensity therapy can lead to subtherapeutic drug levels and reduced efficacy
Reduced cellular protection, impaired detoxification, increased inflammation, and accelerated biological aging
Merit Pharmaceutical shall not be liable for any damageswhether direct, indirect, incidental, consequential, special, or otherwisearising out of or in connection with the use of, or reliance on, any information provided on this website.
